Navigating Ipilimumab and Nivolumab Treatment for Mesothelioma: Insights from the United Kingdom
|

Navigating Ipilimumab and Nivolumab Treatment for Mesothelioma: Insights from the United Kingdom

ByHolly Zink

Being diagnosed with mesothelioma is tough. However, it’s vital to know about new treatments and their effects. In the United Kingdom, Ipilimumab and Nivolumab (IPI/NIVO) are now the top treatments. A new article in Lung Cancer reviews Ipilimumab and Nivolumab results and factors, using a study from a UK hospital. Understanding the Treatment Landscape The arrival of IPI/NIVO has changed mesothelioma treatment. It comes from the CHECKMATE 743 study, which showed great results. This treatment improves survival more than standard chemotherapy. It’s especially good for patients with non-epithelioid mesothelioma. The side effects of IPI/NIVO are similar to those in other cancers. A study at a UK center looked at mesothelioma patients on IPI/NIVO treatment. It aimed to check its real-world…

Examining the Hype: Lackluster Performance of New Mesothelioma Treatment
| | | |

Examining the Hype: Lackluster Performance of New Mesothelioma Treatment

ByHolly Zink

Researchers have found that povidone-iodine treatment does not improve survival in mesothelioma patients. The study comes from King’s College and Guy’s Hospital in the United Kingdom. Survival in Mesothelioma Patients Mesothelioma is a type of cancer that is rare and hard to treat. It is caused by exposure to asbestos and usually occurs in the lungs or abdomen. The prognosis for mesothelioma patients is poor, but survival can be improved with a treatment plan that includes surgery, chemotherapy, or radiation. Researchers have been looking for decades for different ways to improve the survival of people with mesothelioma. One idea that is promising is using a solution called povidone-iodine during surgery. It is used to remove mesothelioma tissue from a patient….